Tatva Chintan Pharma Chem Profit & Loss Annual

BSE: 543321 | NSE: TATVA | ISIN: INE0GK401011 | Sector: Chemical Manufacturing

1,226.95 -6.80 (-0.55%)Updated : 18 Apr 2024

Interim Data

Annual Data

Fiscal Period	2023	2022	2021	2020
Period End Date	Mar 23	Mar 22	Mar 21	Mar 20
Revenue	423.61	433.65	300.36	263.24
Total Revenue	423.61	433.65	300.36	263.24
Costof Revenue Total	258.20	230.30	168.28	141.73
Gross Profit	165.41	203.35	132.08	121.51
Selling/ General/ Admin Expenses Total	97.39	94.83	65.57	63.31
Depreciation/ Amortization	9.56	8.18	6.73	4.79
Other Operating Expenses Total	0.13	0.16	0.00	-
Total Operating Expense	365.28	333.46	240.59	210.85
Operating Income	58.34	100.19	59.77	52.39
Interest Inc( Exp) Net- Non- Op Total	-114.01	44.54	1.03	-53.37
Gain( Loss)on Saleof Assets	-35.88	-0.51	-0.34	-0.31
Other Net	1.43	-0.47	0.86	0.58
Net Income Before Taxes	44.78	104.12	60.70	47.60
Provisionfor Income Taxes	-0.71	8.25	8.43	9.81
Net Income After Taxes	45.49	95.87	52.26	37.79
Net Income Before Extra Items	45.49	95.87	52.26	37.79
Net Income	45.49	95.87	52.26	37.79
Income Availableto Com Excl Extra Ord	45.49	95.87	52.26	37.79
Income Availableto Com Incl Extra Ord	45.49	95.87	52.26	37.79
Diluted Net Income	45.49	95.87	52.26	37.79
Diluted Weighted Average Shares	2.22	2.15	2.22	2.22
Diluted EPS Excluding Extra Ord Items	20.52	44.59	23.58	17.05
DPS- Common Stock Primary Issue	2.00	2.00	0.00	0.00
Diluted Normalized EPS	21.57	44.62	23.59	17.06
Research Development	-	-	-	10.14